National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 27339 [2019-12369]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 113 / Wednesday, June 12, 2019 / Notices
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892, 301–443–4525,
steinerr@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; R34
Refinement and Testing of Interventions to
Sustain ADHD Treatment Effects.
Date: July 10, 2019.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6153, MSC 9606,
Bethesda, MD 20892, 301–443–2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: June 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12368 Filed 6–11–19; 8:45 am]
Dated: June 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12369 Filed 6–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSK3GLQ082PROD with NOTICES
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive, Room
2114, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Mechanistic Studies on
Chronic Alcohol and Sleep R01 Review Panel
RFA–AA–19–006.
Date: July 26, 2019.
Time: 11:00 a.m. to 2:00 p.m.
VerDate Sep<11>2014
17:00 Jun 11, 2019
Jkt 247001
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1112.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
27339
of automated collection techniques or
other forms of information technology.
Proposed Project: 2020 National Survey
on Drug Use and Health Clinical
Validation Study and Redesign Field
Test (OMB No. 0930–0110)—Revision to
2019 NSDUH Collection
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
2020 NSDUH Main Study—
NSDUH must be updated periodically
to reflect changing substance use and
mental health issues and to continue
producing current data. For the 2020
NSDUH main study the following
changes from 2019 are planned: (1) The
addition of lifetime and recency
questions about vaping anything and
vaping nicotine or tobacco; the addition
of lifetime and recency questions on
synthetic marijuana and synthetic
stimulants; (2) the addition of questions
in concordance with the Diagnostic and
Statistical Manual of Mental Disorders
(DSM), fifth edition criteria (DSM–5) to
measure the occurrence of marijuana
withdrawal symptoms, occurrence of
prescription tranquilizer misuse
withdrawal symptoms and occurrence
of craving for all substances; (3) minor
revisions to the marijuana marketplace
module; and (4) other minor wording
changes to improve the flow of the
interview, increase respondent
comprehension or to be consistent with
text in other questions.
By including these new questions in
NSDUH, estimates may be generated on
the use of these substances among the
general population and allow SAMHSA
to provide national-level estimates
among adults and adolescents on the
use of vaping, synthetic marijuana, and
synthetic stimulants. In addition,
because NSDUH collects demographic,
socioeconomic, and health information
about each respondent, the inclusion of
these questions would permit a more
detailed understanding of factors
associated with their use.
The new questions on craving for all
substances and withdrawal for
marijuana/cannabis were added to the
2020 NSDUH main study to reflect the
updated DSM–5 diagnostic criteria for
substance use disorders. Questions
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 84, Number 113 (Wednesday, June 12, 2019)]
[Notices]
[Page 27339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12369]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; Mechanistic Studies on Chronic
Alcohol and Sleep R01 Review Panel RFA-AA-19-006.
Date: July 26, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2114,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D., Chief Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451-2067, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards., National Institutes of
Health, HHS)
Dated: June 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-12369 Filed 6-11-19; 8:45 am]
BILLING CODE 4140-01-P
